Get started
Author

Yaling Hu

Development of an inactivated vaccine candidate for SARS-CoV-2
2020 · Qiang Gao, Linlin Bao, et al. · Science · 1,431
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
2021 · Zhiwei Wu, Yaling Hu, et al. · The Lancet Infectious Diseases · 572
PDF
SARS-CoV-2 spike protein interacts with and activates TLR41
2021 · Yingchi Zhao, Ming Kuang, et al. · Cell Research · 367
PDF
Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients
2020 · Xiaoli Wang, Xianghua Guo, et al. · Clinical Infectious Diseases · 363
PDF
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
2022 · Kang Wang, Zijing Jia, et al. · Nature · 172
PDF
Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
2022 · Yunlong Cao, Fanchong Jian, et al. · Cell Reports · 155
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
2023 · Tong Ye, Zhouguang Jiao, et al. · Nature · 151
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia
2021 · Eddy Fadlyana, Kusnandi Rusmil, et al. · Vaccine · 144
PDF
Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4
2021 · Yingchi Zhao, Ming Kuang, et al. · Cell Research · 51
PDF
A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
2024 · Zijing Jia, Kang Wang, et al. · Protein & Cell · 42
A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
2021 · Kang Wang, Yunlong Cao, et al. · medRxiv · 41
PDF
Efficacy of Jinhua Qinggan Granules Combined With Western Medicine in the Treatment of Confirmed and Suspected COVID-19: A Randomized Controlled Trial
2021 · XueDong An, Xi Xu, et al. · Frontiers in Medicine · 39
PDF
Molecular Evolution of Protein Sequences and Codon Usage in Monkeypox Viruses
2023 · Ke-Jia Shan, Changcheng Wu, et al. · Genomics Proteomics & Bioinformatics · 23
PDF
Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China
2021 · Xia Feng, Jiming Yin, et al. · Frontiers in Immunology · 22
PDF
A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3-5 years and infants aged 6-35 months
2018 · Wei Gu, Gang Zeng, et al. · Expert Review of Vaccines · 15
The first Chinese national standards for SARS-CoV-2 neutralizing antibody
2021 · Lidong Guan, Yuanling Yu, et al. · Vaccine · 13
PDF
Insights into varicella-zoster virus assembly from the B- and C-capsid at near-atomic resolution structures
2023 · Lei Cao, Nan Wang, et al. · hLife · 9
Single-Cell Sequencing and Immune Function Assays of Peripheral Blood Samples Demonstrate Positive Responses of an Inactivated SARS-CoV-2 Vaccine
2021 · Haoran Zhang, Yaling Hu, et al. · SSRN Electronic Journal · 8
Antibody cocktails based on the occupationally acquired immunity of pediatricians neutralize and confer protection against RSV and hMPV
2026 · Hui Zhai, Wenxiang Yu, et al. · Science Translational Medicine · 7
Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial
2024 · Chaoying Hu, Yibo Zhou, et al. · Pharmaceutics · 7
PDF
Safety and Effectiveness of SA58 Nasal Spray Against COVID-19 Infection in Medical Personnel: An Open-Label, Blank-Controlled Study — Hohhot City, Inner Mongolia Autonomous Region, China, 2022
2023 · Shujie Si, Canrui Jin, et al. · China CDC Weekly · 6
PDF
Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge
2021 · Yinfeng Shen, Yuanming Ba, et al. · Inflammation Research · 6
PDF
Lysosomal “TRAP”: a neotype modality for clearance of viruses and variants
2024 · Chengliang Lyu, Zhanlong He, et al. · Nature Communications · 4
PDF
Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial
2023 · Jialei Hu, Yueyue Liu, et al. · Frontiers in Immunology · 4
PDF
Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study — Yunnan Province, China, 2021–2022
2023 · Haitao Yang, Xing Meng, et al. · China CDC Weekly · 4
PDF
Works count: 36
Citation count: 3,664
H-index: 15
I10-index: 16
Year
Topic
Type